[Progress of clinical trials on breast cancer in China, 2011-2022].

View at publisher Summarise with VIRAT
Authors: Y Fang, H Y Huang, D W Wu, Yue Yu, Ye Leng, Y Tang, N Li
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Substantial achievements have been made in the development of new breast cancer drugs in China from 2011 to 2022. However, there remains a significant gap in the innovation capabilities of domestic pharmaceutical companies compared to international counterparts in the field of breast cancer. Future efforts should be directed towards strengthening research and development in breast cancer, exploring new target points, and investigating combination therapy mechanisms.

Fields of Study & Subjects

Breast Cancer Treatment Studies Advanced Breast Cancer Therapies Cancer Treatment and Pharmacology

Publication details

Journal / source
PubMed
Volume
48
Issue
3
Pages
445–450
Publication date
23 March 2026
Language
ZH